The city of Marietta, Ga., has joined a growing list of unions and local governments to file a lawsuit contending Mallinckrodt (MNK) caused them to spend excessively for a medicine because of its high price. The city also alleges the company used several purportedly inappropriate tactics designed to boost usage.
In their lawsuit, Marietta officials argued the city’s self-funded health plan was forced to spend more than it should have because of the “exorbitant and unconscionable” price charged for Acthar Gel, which is used to treat infantile spasms and relapsing multiple sclerosis.
About the Author Reprints
